1. A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs. Issue 4 (4th July 2021) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Modern rheumatology Issue: Volume 31:Issue 4(2021) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses. (31st May 2017) Authors: Tamai, Toshiyuki; Hayato, Seiichi; Hojo, Seiichiro; Suzuki, Takuya; Okusaka, Takuji; Ikeda, Kenji; Kumada, Hiromitsu Journal: Journal of clinical pharmacology Issue: Volume 57:Number 9(2017) Page Start: 1138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle‐controlled exploratory trial. Issue 8 (24th December 2015) Authors: Nemoto, Osamu; Hayashi, Nobukazu; Kitahara, Yasumi; Furue, Masutaka; Hojo, Seiichiro; Nomoto, Maiko; Shima, Satoshi Other Names: Asanuma Hiroyuki investigator.; Saga Kenji investigator.; Takahashi Yoshimasa investigator.; Morikawa Reiko investigator.; Hagiwara Kazuya investigator.; Sugawara Hiroshi investigator.; Takata Hideyasu investigator.; Etoh Takafumi investigator. Journal: Journal of dermatology Issue: Volume 43:Issue 8(2016) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study. Issue 4 (18th February 2021) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Arthritis & rheumatology Issue: Volume 73:Issue 4(2021) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study. (2nd September 2016) Authors: Ohba, Fuminori; Matsuki, Shunji; Imayama, Shuhei; Matsuguma, Kyoko; Hojo, Seiichiro; Nomoto, Maiko; Akama, Hideto Journal: Journal of dermatological treatment Issue: Volume 27:Number 5(2016:Oct.) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers. Issue 4 (11th October 2022) Authors: Yamakawa, Naoto; Tago, Fumitoshi; Nakai, Kenya; Kitahara, Yasumi; Ikari, Shingo; Hojo, Seiichiro; Hall, Nancy; Aluri, Jagadeesh; Hussein, Ziad; Gevorkyan, Hakop; Maruyama, Tatsuya; Ishizaka, Sally; Yagi, Takuya Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 4(2023) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0223 EFFICACY AND SAFETY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis. (4th July 2019) Authors: Kitahara, Yasumi; Hojo, Seiichiro; Nomoto, Maiko; Onozuka, Daisuke; Furue, Masutaka; Hagihara, Akihito Journal: Journal of dermatological treatment Issue: Volume 30:Number 5(2019) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease. Issue 8 (31st March 2021) Authors: Matsuoka, Katsuyoshi; Naganuma, Makoto; Hibi, Toshifumi; Tsubouchi, Hirohito; Oketani, Kiyoshi; Katsurabara, Toshinori; Hojo, Seiichiro; Takenaka, Osamu; Kawano, Tetsu; Imai, Toshio; Kanai, Takanori Journal: Journal of gastroenterology and hepatology Issue: Volume 36:Issue 8(2021) Page Start: 2180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan. Issue 9 (14th July 2021) Authors: Izutsu, Koji; Ando, Kiyoshi; Nishikori, Momoko; Shibayama, Hirohiko; Teshima, Takanori; Kuroda, Junya; Kato, Koji; Imaizumi, Yoshitaka; Nosaka, Kisato; Sakai, Rika; Hojo, Seiichiro; Nakanishi, Tadashi; Rai, Shinya Journal: Cancer science Issue: Volume 112:Issue 9(2021) Page Start: 3627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗